Calyxt (CLXT) IPO Opens, Trades Higher

Today's IPO for Calyxt (NASDAQ: CLXT) opened for trading earlier at $9.50 after pricing 7,000,000 shares of its common stock at the initial public offering price of $8.00 per share. The number of shares in the Offering represents an increase of 939,394 shares from the 6,060,606 shares previously disclosed, and the initial public offering price represents a decrease from the previously disclosed estimated price range of $15.00 to $18.00 per share. Shares of CLXT last traded at $11.54, up 44%.

Citigroup, Jefferies and Wells Fargo Securities are acting as joint book-running managers for the proposed offering. BMO Capital Markets and Ladenburg Thalmann are acting as co-managers.

Calyxt is a spin-off from Cellectis S.A. (NASDAQ: CLLS).

Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. By combining its leading gene-editing technology and technical expertise with its innovative commercial strategy, Calyxt is pioneering a paradigm shift to deliver both healthier specialty food ingredients, such as healthier oils and high fiber wheat for consumers as well as agriculturally advantageous traits, such as herbicide tolerance to farmers.

You May Also Be Interested In

• CopperTech Metals files for IPO on NYSE under ticker CUX
• SpaceX bond sale draws $89 billion in investor demand
• Doncasters Group guiding IPO pricing at top of range - Bloomberg